A quinazoline and pyrido[3,2- d ]pyrimidine based compound library was designed, synthesized and evaluated as multi-targeting agents aimed at Alzheimer's disease (AD).
No takes yet. Share an insight, caveat, or question.
Mohamed et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: